Insights On Upstream Manufacturing
-
An Alternative Genetic Engineering Tool In CHO Cells
8/15/2025
Discover how transposon technology is being reimagined as a precise genetic engineering tool to create high-performing CHO cell lines for biotherapeutic production with enhanced metabolic and glycan profiles.
-
Developing An In Vivo CAR-T With Interius BioTherapeutics' Sianny Christanti and Babu Medi, Ph.D.
8/12/2025
On this episode of Better Biopharma, Interius BioTherapeutics’ Sianny Christanti and Babu Medi, Ph.D., explain how the company is re-engineering a lentiviral vector to enable INT2104, its off-the-shelf, in vivo CAR T-cell therapy. They discuss the vector's design and its manufacturability, as well as the analytical and regulatory challenges of bringing this first-in-human therapy to the clinic.
-
Seed Train Intensification Using High Cell Density Cryopreservation
8/11/2025
Streamline your upstream bioprocessing with seed train intensification. Discover how high cell density cryopreservation reduces scale-up time, boosts consistency, and enhances manufacturing flexibility.
-
Cell Retention Technology And Specialized Cell Culture Media
8/11/2025
Explore how perfusion technology is transforming upstream bioprocessing by boosting productivity, reducing costs, and enabling process intensification while overcoming cell retention challenges.
-
Facts About AAV Producer Cell Lines
8/8/2025
Gene therapies are revolutionizing medicine, with AAV vectors leading the way. As production evolves, stable cell lines may replace transient transfection and unlock scalable solutions.
-
Enhance Lab Productivity And Ensure Reliability: Shaking Incubator Proactive Service
8/7/2025
Regular preventive maintenance is essential for ensuring the longevity and optimal performance of your shaking incubator. Find out how this approach helps avoid costly downtime and protects your research.
-
Bioconversion Of Babassu Mesocarp Flour Into Single-Cell Protein In A Controlled Bioreactor System
8/7/2025
Discover how the continuous feeding of babassu hydrolysate to yeast cultures can efficiently transform a byproduct into a protein-rich ingredient for plant-based foods.
-
Optimized Expression Systems For Increased Productivity
8/7/2025
Discover innovative strategies to boost CHO DG44 cell line productivity, as well as explore optimized expression systems that enhance yield, stability, and efficiency in protein development.
-
Expand Your Capabilities And Shorten Your Time-To-Clinic
8/7/2025
Gain expert insights into cell line development for biologics commercialization. and learn how CLD services—from DNA to GMP Master Cell Bank—can accelerate your path to clinical success.
-
Reducing Risk, Decreasing Timelines, And Optimizing Outcomes
8/7/2025
Explore the challenges of cell line development (CLD) in biologics commercialization and discover how integrated solutions can streamline your strategy, reduce risks, and optimize outcomes.